Yuon Control AG wins the Ypsomed Innovation Award 2025.

Yuon Control AG wins Ypsomed Innovation Award 2025

Press Releases Ypsomed Group

Burgdorf –The winners of the Ypsomed Innovation Award 2025 were honoured yesterday evening at the EVENTfabrik in Bern. First place went to Yuon Control AG. Xemperia and Santella also made it onto the winners' podium. The Innovation Award, which grants a total of CHF 100,000 to the recipients, was awarded for the eleventh time by the Ypsomed Innovation Fund Foundation. The aim is to promote the transfer of knowledge and technology from universities of applied sciences and universities in the Swiss midlands to the industry. 

Topics:
Innovation & Digital Health

Read more...

Ypsomed significantly increases sales and decides to initiate the sale of Diabetes Care

Ad hoc announcement pursuant to Art. 53 LR

Burgdorf – Ypsomed (SIX: YPSN) continues its growth trend and achieved consolidated sales of CHF 255.4 million in the first six months of the 2023/24 financial year (previous year: CHF 244.2 million). 

Read more...

Ypsomed and BD collaborate to advance self-injection systems for high viscosity biologics

Press Releases Ypsomed Group

Burgdorf – Ypsomed (SIX: YPSN) announced a strategic collaboration with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, to advance self-injection solutions for high-viscosity biologic drugs

Topics:
Innovation & Digital Health

Read more...

Ypsomed opens new production hall in Schwerin and announces further expansion

Press Releases Ypsomed Group

Burgdorf – Today Ypsomed celebrates the opening of a new production hall at its German site in Schwerin. The expansion will enable the company to increase its production capacity to meet the growing global demand for high-quality medical technology products. CEO of Ypsomed, Simon Michel, also announced a further expansion of the plant in the coming years.

Topics:
Access & Expansion

Read more...

Ypsomed and MTD complete the sale of the pen needle and BGM business

Press Releases Ypsomed Group

Burgdorf – Ypsomed and Medical Technology and Devices S.p.A. (MTD) have completed the sale of the pen needle and blood glucose monitoring (BGM) systems business. This transaction marks a pivotal moment for Ypsomed, as it allows the company to focus its diabetes care business on commercialisation and development of its innovative mylife Loop insulin pump solution.

Topics:
Management

Read more...